Astellas Pharma Inc. and Subsidiaries  As of the date of transition to IFRS (1 April 2012), and 31 March 2013 and 2014 consoliDateD stateMents of financial position Astellas Pharma Inc.  _ Annual Report 2014 104 (Millions of yen) (Millions of U.S. dollars) Note 1 April 2012  (Transition date) 2013 2014 2014 Assets Non-current assets Property, plant and equipment 15 ¥ 192,851 ¥ 211,112 ¥ 191,451 $ 1,859 Goodwill 16 94,193 107,648 116,766 1,134 Other intangible assets 17 367,220 340,603 280,120 2,720 Investments in associates and joint ventures 830 1,204 1,808 18 Deferred tax assets 18 57,399 45,178 45,530 442 Other financial assets 19 76,676 81,084 94,961 922 Other non-current assets 20 5,532 5,724 9,179 89 Total non-current assets 794,700 792,553 739,816 7,183 Current assets Inventories 21 112,705 127,095 135,228 1,313 Trade and other receivables 22 288,317 308,208 332,639 3,230 Income tax receivable 6,605 10,492 2,710 26 Other financial assets 19 48,814 50,934 35,406 344 Other current assets 20 6,089 9,440 12,068 117 Cash and cash equivalents 23 252,380 264,912 391,374 3,800 Sub total 714,911 771,082 909,424 8,829 Assets held for sale 24 1,451 1,636 3,868 38 Total current assets 716,361 772,718 913,292 8,867 Total assets ¥1,511,061 ¥1,565,271 ¥1,653,108 $16,050